BMRN
Biomarin Pharmaceutical Inc. - Registered Shares

5,342
Mkt Cap
$11.71B
Volume
803,120.00
52W High
$73.18
52W Low
$50.76
PE Ratio
34.17
BMRN Fundamentals
Price
$60.51
Prev Close
$60.89
Open
$60.26
50D MA
$59.07
Beta
0.71
Avg. Volume
2.43M
EPS (Annual)
$1.80
P/B
1.92
Rev/Employee
$1.01M
$10,813.39
Loading...
Loading...

About

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
3,221

Frequently Asked Questions

What is Market Cap of Biomarin Pharmaceutical Inc. - Registered Shares?
What is the 52-week high for Biomarin Pharmaceutical Inc. - Registered Shares?
What is the 52-week low for Biomarin Pharmaceutical Inc. - Registered Shares?
What is Biomarin Pharmaceutical Inc. - Registered Shares stock price today?
What was Biomarin Pharmaceutical Inc. - Registered Shares stock price yesterday?
What is the PE ratio of Biomarin Pharmaceutical Inc. - Registered Shares?
What is the Price-to-Book ratio of Biomarin Pharmaceutical Inc. - Registered Shares?
What is the 50-day moving average of Biomarin Pharmaceutical Inc. - Registered Shares?
How many employees does Biomarin Pharmaceutical Inc. - Registered Shares have?

Latest BMRN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.